Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Purchases of Investments

-$33.60M

TTM · Period ending: · USD

LCTX logo

LCTX Purchases of Investments

Latest reported-$33.60M
LCTX TTM Purchases of Investments ($0.00 → -$33.60M)
High-resolution chart · PNG

LCTX purchases of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Purchases of Investments — Trailing twelve months (TTM) (USD)
Period endingPurchases of Investments (USD)
-33,598,000
-23,171,000
-14,935,000
0
0
-8,761,000
-8,761,000
-8,761,000
-12,529,000
-8,685,000
-16,403,000
-29,187,000
-66,047,000
-61,130,000
-53,412,000
-40,628,000
0
0
0
16,682,000
16,486,000
16,486,000
11,265,000
-5,417,000
-5,221,000
-5,221,000
0
0
0
0
0
-189,000
-189,000
-189,000
-189,000
0
0
0
0
-748,000
-748,000
-748,000
-748,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.